BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8565277)

  • 1. Transforming growth factor-beta 1 (TGF-beta 1) down-regulates IgA Fc-receptor (CD89) expression on human monocytes.
    Reterink TJ; Levarht EW; Klar-Mohamad N; Van Es LA; Daha MR
    Clin Exp Immunol; 1996 Jan; 103(1):161-6. PubMed ID: 8565277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and Fc alpha R (CD89)-mediated down-regulation of tumour necrosis factor-alpha (TNF-alpha) and IL-6 in human monocytes.
    Wolf HM; Hauber I; Gulle H; Samstag A; Fischer MB; Ahmad RU; Eibl MM
    Clin Exp Immunol; 1996 Sep; 105(3):537-43. PubMed ID: 8809146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD32 expression and signaling is down-regulated by transforming growth factor-beta 1 on human monocytes.
    Reterink TJ; Klar-Mohamad N; Nibbering PH; van Es LA; Daha MR
    Eur J Immunol; 1996 Aug; 26(8):1970-3. PubMed ID: 8765047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells.
    Leung JCK; Tsang AWL; Chan DTM; Lai KN
    J Am Soc Nephrol; 2000 Feb; 11(2):241-249. PubMed ID: 10665931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human mesangial cells in culture and in kidney sections fail to express Fc alpha receptor (CD89).
    Westerhuis R; Van Zandbergen G; Verhagen NA; Klar-Mohamad N; Daha MR; van Kooten C
    J Am Soc Nephrol; 1999 Apr; 10(4):770-8. PubMed ID: 10203361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subset of human dendritic cells expresses IgA Fc receptor (CD89), which mediates internalization and activation upon cross-linking by IgA complexes.
    Geissmann F; Launay P; Pasquier B; Lepelletier Y; Leborgne M; Lehuen A; Brousse N; Monteiro RC
    J Immunol; 2001 Jan; 166(1):346-52. PubMed ID: 11123311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-4 antagonizes induction of Fc gamma RIII (CD16) expression by transforming growth factor-beta on human monocytes.
    Wong HL; Welch GR; Brandes ME; Wahl SM
    J Immunol; 1991 Sep; 147(6):1843-8. PubMed ID: 1653804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel Fcalpha receptor expressed by human mesangial cells.
    Barratt J; Greer MR; Pawluczyk IZ; Allen AC; Bailey EM; Buck KS; Feehally J
    Kidney Int; 2000 May; 57(5):1936-48. PubMed ID: 10792612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced binding of immunoglobulin A (IgA) from patients with primary IgA nephropathy to the myeloid IgA Fc-receptor, CD89.
    van Zandbergen G; van Kooten C; Mohamad NK; Reterink TJ; de Fijter JW; van de Winkel JG; Daha MR
    Nephrol Dial Transplant; 1998 Dec; 13(12):3058-64. PubMed ID: 9870466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA nephropathy-specific expression of the IgA Fc receptors (CD89) on blood phagocytic cells.
    Toyabe S; Kuwano Y; Takeda K; Uchiyama M; Abo T
    Clin Exp Immunol; 1997 Nov; 110(2):226-32. PubMed ID: 9367406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities.
    Smith PD; Smythies LE; Mosteller-Barnum M; Sibley DA; Russell MW; Merger M; Sellers MT; Orenstein JM; Shimada T; Graham MF; Kubagawa H
    J Immunol; 2001 Sep; 167(5):2651-6. PubMed ID: 11509607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice.
    Launay P; GrossetĂȘte B; Arcos-Fajardo M; Gaudin E; Torres SP; Beaudoin L; Patey-Mariaud de Serre N; Lehuen A; Monteiro RC
    J Exp Med; 2000 Jun; 191(11):1999-2009. PubMed ID: 10839814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative splicing of myeloid IgA Fc receptor (Fc alpha R, CD89) transcripts in inflammatory responses.
    Togo S; Shimokawa T; Fukuchi Y; Ra C
    FEBS Lett; 2003 Jan; 535(1-3):205-9. PubMed ID: 12560105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD89: the human myeloid IgA Fc receptor.
    Morton HC; Brandtzaeg P
    Arch Immunol Ther Exp (Warsz); 2001; 49(3):217-29. PubMed ID: 11478396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human IgA-Fc alpha receptor interaction and its blockade by streptococcal IgA-binding proteins.
    Woof JM
    Biochem Soc Trans; 2002 Aug; 30(4):491-4. PubMed ID: 12196121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonhuman primate IgA: genetic heterogeneity and interactions with CD89.
    Rogers KA; Jayashankar L; Scinicariello F; Attanasio R
    J Immunol; 2008 Apr; 180(7):4816-24. PubMed ID: 18354205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Fc alpha receptor (CD89) isoforms generated by alternative splicing that are differentially expressed between blood monocytes and alveolar macrophages.
    Patry C; Sibille Y; Lehuen A; Monteiro RC
    J Immunol; 1996 Jun; 156(11):4442-8. PubMed ID: 8666819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of Fc alpha receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA.
    GrossetĂȘte B; Launay P; Lehuen A; Jungers P; Bach JF; Monteiro RC
    Kidney Int; 1998 May; 53(5):1321-35. PubMed ID: 9573548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injection of recombinant FcalphaRI/CD89 in mice does not induce mesangial IgA deposition.
    van der Boog PJ; van Kooten C; van Zandbergen G; Klar-Mohamad N; Oortwijn B; Bos NA; van Remoortere A; Hokke CH; de Fijter JW; Daha MR
    Nephrol Dial Transplant; 2004 Nov; 19(11):2729-36. PubMed ID: 15340093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and modulation of the human immunoglobulin A Fc receptor (CD89) and the FcR gamma chain on myeloid cells in blood and tissue.
    Hamre R; Farstad IN; Brandtzaeg P; Morton HC
    Scand J Immunol; 2003 Jun; 57(6):506-16. PubMed ID: 12791088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.